Although we did not include patients with SLE in the present study, and thus could not directly compare serum AIMP1 between the two diseases, these results suggest that the dynamic range of the serum concentration of AIMP1 to estimate disease severity might be autoimmune disease-specific. This evidence concerns the gene AIMP1 and autoimmune disease.